Why the study?
Does oxprenolol alone and combined with nitroglycerin improve acute hemodynamic parameters in males with ischemic heart disease?
Does oxprenolol alone and combined with nitroglycerin improve acute hemodynamic parameters in males with ischemic heart disease?
Oxprenolol and nitroglycerin can be safely combined to reduce myocardial oxygen demand in patients with ischemic heart disease, though their hemodynamic effects are not synergistic.
Answers are grounded in this paper and cite their sources.
Findings hypothesis-generating in ischemic heart disease; leaves open whether combination improves outcomes or warrants routine use.
In 16 males with ischemic heart disease the acute hemodynamic effects of a new β‐blocker, oxprenolol, have been studied during rest and exercise by right heart catheterization technique. The myocardial oxygen‐saving effect of oxprenolol was demonstrated by a significant reduction of heart rate during exercise and a widened arterio‐venous oxygen difference. Addition of nitroglycerin rapidly and markedly reduced myocardial oxygen demand by reducing the left ventricular filling pressure and the mean systemic arterial pressure. Oxprenolol and nitroglycerin can be combined without any untoward effects and without loss of efficiency of either drug. However, no evidence of synergism between the two drugs was found in this study.
No takes yet. Share an insight, caveat, or question.
Lecerof et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: